Figure 1From: Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy Disposition of patients. AE = adverse event, ANC = absolute neutrophil count.Back to article page